Clinical Trial Update: Anakinra to Prevent Adverse Post-infarction Remodeling (2) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated anakinra to prevent adverse remodeling after acute myocardial infarction, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Myocardial Infarction

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Acute Myocardial Infarction, Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2016-05-23